Joe Yu 6/29/26 Joe Yu 6/29/26 The In Vivo CAR-T Race Heats Up Read More Joe Yu 6/29/26 Joe Yu 6/29/26 CD8-eGFP-LNP shows high percentage of conjugated LNP, and high degree of CD8-cell- specific transfection Read More Joe Yu 6/29/26 Joe Yu 6/29/26 Tiva Biosciences is pleased to launch off-the-shelf products to accelerate targeted-LNP development Read More Joe Yu 6/29/26 Joe Yu 6/29/26 Tiva Biosciences is proud to introduce Ready-to-Target binder-lipid product Read More Joe Yu 6/29/26 Joe Yu 6/29/26 A stability boost for in vivo Cell and Gene Therapy Read More Joe Yu 6/29/26 Joe Yu 6/29/26 tLNP engineering modularized – cutting weeks off the tLNP workflow Read More
Joe Yu 6/29/26 Joe Yu 6/29/26 CD8-eGFP-LNP shows high percentage of conjugated LNP, and high degree of CD8-cell- specific transfection Read More
Joe Yu 6/29/26 Joe Yu 6/29/26 Tiva Biosciences is pleased to launch off-the-shelf products to accelerate targeted-LNP development Read More
Joe Yu 6/29/26 Joe Yu 6/29/26 Tiva Biosciences is proud to introduce Ready-to-Target binder-lipid product Read More
Joe Yu 6/29/26 Joe Yu 6/29/26 tLNP engineering modularized – cutting weeks off the tLNP workflow Read More
